Back

Zymeworks completes acquisition of Theravance Biopharma

Verifying
  • Zymeworks completed its previously announced acquisition of Theravance Biopharma.
  • Zymeworks will host an investor call September 28 at 8:30 a.m. ET.
  • Theravance Biopharma is now part of Zymeworks following completion of the transaction.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.